Home » Market News » DirectorsTalk Highlights » VIVODOTS Nanoparticles
Nanoco Group PLC

VIVODOTS Nanoparticles

Medicine is becoming ever more sophisticated. The intersection of new medical knowledge and changing population health needs is creating new opportunities and demand for products based on Nanoco’s nanomaterials. Nanoco will play a crucial role in crafting solutions and delivering unique products into the life science research, pharmaceutical development and routine clinical arenas.

Nanoco’s VIVODOTS™ nanoparticles represent a new class of material that has the potential to be applied in a range of techniques. Unique in its lack of toxic metals, it can be used for medical and veterinary applications such as diagnostic imaging and phototherapy, and potentially for targeted drug delivery. We have the opportunity to contribute to the development of new perspectives of disease biology, opening up new horizons for disease diagnosis and the tailoring and monitoring of therapeutic interventions, and ultimately impacting health care delivery and quality of life.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.